Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gallet, P. F.
Right arrow Articles by Julien, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gallet, P. F.
Right arrow Articles by Julien, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology Pages 919-925  


Heterologous expression of an engineered truncated form of human Lewis fucosyltransferase (Fuc-TIII) by the methylotrophic yeast Pichia pastoris
Introduction
Results
Discussion
Materials and methods
Acknowledgments
Abbreviations
References


Heterologous expression of an engineered truncated form of human Lewis fucosyltransferase (Fuc-TIII) by the methylotrophic yeast Pichia pastoris

Heterologous expression of an engineered truncated form of human Lewis fucosyltransferase (Fuc-TIII) by the methylotrophic yeast Pichia pastoris

Paul François Gallet, Hélène Vaujour, Jean-Michel Petit, Abderrahman Maftah, Ahmad Oulmouden, Rafael Oriol1, Christine Le Narvor2, Michel Guilloton, Raymond Julien3

Institut de Biotechnologie, Université de Limoges, France, 1INSERM U-178, Université de Paris-Sud XI, 94807 Villejuif, France and 2URA CNRS 462, Université Paris-Sud, 91405 Orsay Cedex, France

Received on January 15, 1998; accepted on March 2, 1998

A stable GS115 Pichia pastoris recombinant strain was constructed to secrete a truncated form of the human [alpha](1,3/4) fucosyltransferase (amino acids 45-361). Enzyme production resulted from a secretory pathway based on the pre-pro- [alpha] mating factor signal sequence of the yeast Saccharomyces cerevisiae. Following its transit through the Golgi apparatus, the enzyme accumulated in the periplasmic space before its release in the culture broth (about 30 mg/l). Cell-enclosed enzyme (~0.16%) proved to be fairly stable for many freezing and thawing cycles and could be used several times as an immobilized catalyst. Soluble enzyme (>99.8%) representing the main protein of the culture broth (10%) has been characterized by Western-blotting, substrate specificities and kinetic parameters. The two forms (cell-enclosed and soluble) of recombinant enzyme may be used for in vitro synthesis of Lewisa determinants.

Key words: glycosyltransferase/Lewis a/Pichia pastoris

Introduction

Synthesis of Lewis a (Lea), Lewis×(Lex), sialyl-Lewis a (sLea), and sialyl-Lewis x (sLex) determinants requires Lewis blood group [alpha](1,3/4) fucosyltransferase (Fuc-TIII) (Kukowska-Latallo et al., 1990). Fucosylated cell surface glycoconjugates belonging to the Lewis group system have been shown to be physiologically important. Lea and Leb are the major Lewis antigens found on human erythrocytes. The fucosylated glycosphingolipids are synthesized by exocrine epithelial cells (Oriol et al., 1986) and then passively adsorbed onto erythrocytes in the peripheral circulation giving these blood cells their Lewis phenotype (Marcus and Cass, 1969). The determinant sLex is found at the surface of leukocytes and tumor cells (Walz et al., 1990) whereas sLea is mostly found at the surface of cancer cells of the digestive tract (Takada et al., 1991). The cell surface glycoconjugates are essential for adhesion between leukocytes and vascular endothelium during the inflammatory reaction. During this process, leukocytes interact with E-selectin present at the surface of endothelial cells via sLex structures (Lowe et al., 1990; Berg et al., 1992; Foxall et al., 1992). The two determinants have also been shown to be components of ligands for L- and P-selectins (Berg et al., 1992; Foxall et al., 1992).

Easy and cost-effective means for obtaining large amounts of isolated Fuc-TIII are needed for: (1) its use in chemo-enzymic synthesis of fucosylated substrates, (2) x-ray crystallography and NMR spectroscopy, (3) synthesis of sLea and sLex determinants as potential tools for treatment of inflammatory diseases or the prevention of metastases.

For these purposes, we have undertaken the synthesis and characterization of a truncated human Fuc-TIII enzyme by the methylotrophic yeast Pichia pastoris, a cell which produces 30% of total soluble protein as alcohol oxidase when it uses methanol as a carbon source (Ellis et al., 1985; Cregg et al., 1993). Truncated Fuc-TIII synthesis is under the control of this methanol inducible alcohol oxidase (AOX1) promoter and the yeast secretes the protein through the secretory pathway using the pre-pro [alpha]-mating factor signal sequence.

Results

Construction of a pPIC9 recombinant vector containing a truncated human FUT3 coding sequence

A 1125 bp coding sequence located between the two engineered EcoRI and XbaI sites of pcDNAI containing FUT3 gene and corresponding to the full length Fuc-TIII peptidic sequence, was transferred to the EcoRI and AvrII sites of pPIC9 polylinker, leading to the pPIC9[FUT3] vector. Then, a 1002 pb fragment located between the AvrII site downstream from the transmembrane domain of FUT3 gene and the NotI site of pPIC9[FUT3] was cloned into the pPIC9 vector (Figure 1A). The final construct contained the human FUT3 coding sequence lacking the 132 bp corresponding to cytosolic and transmembrane domains and to the N-ter of the stem region (44 amino acids). This construct was located downstream from the [alpha]-factor signal sequence of the yeast Saccharomyces cerevisiae and was under the control of the yeast alcohol oxidase promoter (5[prime]AOX1, Figure 1B). The resulting pPIC9[FUT3t] plasmid was linearized by digestion with SalI and transferred by electroporation into the GS115 Pichia pastoris (his4) yeast strain (Figure 1C). Consequently, the truncated protein, N-extended by four extra amino acids, synthesized along the secretory pathway will be released after two specific proteolytic cleavages (Figure 1A).


Figure 1. Construction of the Fuc-TIII expression vector and genomic integration.Relevant cloning sites AvrII and NotI were located downstream from the [alpha]-factor signal sequence and upstream from the 3[prime]AOX1 transcription termination fragment (TT), respectively. (A) Italic codons correspond to the [alpha]-factor signal sequence. Boldface codons represent the limits of truncated FUT3 sequence. Shaded protein sequence indicates protease cleavage sites for KEX2 (arrow and *) and STE13 (arrow and **) gene products, respectively. The amino-terminus sequence of the recombinant protein is indicated in one letter code boldface characters. Circular form of pPIC9[FUT3t] plasmid (B) was linearized by cleavage to SalI site located in the wild type HIS4 gene. The linear plasmid containing the FUT3t expression cassette (C) was integrated into the mutated his4 locus of the yeast genome, generating one mutant (his4) and one wild-type (HIS4) chimeric sequences. AOX1, Alcohol oxidase gene sequence; 5[prime]AOX1, AOX1 promoter region; 3[prime]AOX1 (TT), Transcription termination fragment; HIS4, wild type gene encoding histidinol dehydrogenase; S, [alpha]-factor signal sequence of S.cerevisiae.

Expression of the truncated Fuc-TIII enzyme

Stable transformants were selected for histidine prototrophy by plating on a dextrose-YNB medium without histidine. Plasmid integration was analyzed on 10 His+ integrants, presenting a high growth rate, by PCR using 5[prime]and 3[prime]AOX1 primers corresponding to flanking sequences of the native AOX1 gene (Figure 2). Eight positive integrants provided the expected 1498 bp PCR product. Clones 10 and 20 which lack the 1498 bp fragment appeared as spontaneous revertants.


Figure 2. PCR analysis of the FUT3t gene integration. Genomic DNA of Pichia pastoris clones transformed by pPIC9[FUT3t] was analyzed by PCR using AOX1-specific primers (Materials and methods). Integrated sequence yields a PCR product of 1498 bp, whereas the wild-type AOX1 gene yields a product of 2200 bp. Clones 1, 2, 8, 14, 15, 16, 22, and 25 had incorporated the FUT3t sequence into the his4 locus. Clones 10 and 20 were false positives. M, Molecular markers.

The expression levels of functional Fuc-TIII enzyme in 1% methanol-induced recombinant GS115 cells (see Materials and methods), were significantly different from one clone to another as revealed by fucose transfer to the type 1 substrate (Table I). Clone 25 that showed the highest expression level was selected for further characterizations.

Table I. Human fucosyltransferase activity of Pichia cells transformed by pPIC9[FUT3t]
Clone number 1 2 8 10 14 15 16 20 22 25
[14C]Fucose 1.1 1.5 1.5 - 1.5 1.4 1.45 - 1.25 2
(c.p.m.·10-6/h·mg prot.)
Type 1 acceptor (0.1 mM) and 2.8 µM GDP-[14C]fucose (100,000 c.p.m.) were added to 25 µg protein of a cell homogenate. The incubation time was 1 h at 37°C.

Fuc-TIII enzyme remained at first enclosed in the cell and its release in culture broth occurred 38 h after the beginning of methanol induction. In order to better understand the intracellular processing of the truncated human Fuc-TIII enzyme, we determined its subcellular distribution. As expected, the truncated Fuc-TIII activity was mainly located (85.5%) into the cytosol (probably in exocytosis vesicles) and the periplasmic space (Table II). The transiently resident activity found in the Golgi apparatus was restricted to 5.6%.

Table II. Subcellular distribution of truncated Fuc-TIII enzyme activity
Cellular fraction Fraction volume (ml) Activity c.p.m.·µl-1·h-1 Total activity (c.p.m.@h-1)·10-3 Percentage of activity
Crude extract 4.9 540 ± 92 2591 ± 357 100
Cell wall 1.0 170 ± 14 170 ± 14 6.6
Nuclei 0.1 63 ± 14 6 ± 1 0.2
Mitochondria 0.1 158 ± 19 16 ± 2 0.6
Microsomes 0.2 730 ± 69 146 ± 14 5.6
Cytosol and periplasm 5.7 389 ± 18 2217 ± 103 85.5
Crude extract corresponds to cells contained in 100 ml of culture broth (48 h). Cell pellet was twice washed and disrupted with glass beads. Subcellular fractions were obtained as described in the Materials and methods. Assays (60 µl) contained 24 µl of each fraction, 0.1 mM type 1 acceptor substrate, 2.8 µM GDP-[14C]fucose (100,000 c.p.m.), and were incubated for 1 h at 37°C.

Production by high density fed-batch fermentation and purification of enzyme

An overnight culture (200 ml) in 1% glycerol as a carbon source was carried out in order to inoculate one liter (A600 = 0.86) of fresh medium without glycerol. Fed-batch production of the enzyme was initiated by 1% methanol. Methanol concentration, culture volume, temperature, agitation rate, and pH were maintained during 169 h. Activity of Fuc-TIII enzyme, present in the culture medium or enclosed in cells, was measured all along the experiment (Figure 3).

Whereas the Fuc-TIII activity increased in whole cells during the first 30 h, it was undetectable in supernatant (Figure 3). Then, supernatant Fuc-TIII activity rapidly increased as cell growth slowed down. At the end of the process (169 h), the whole cell-enclosed Fuc-TIII enzyme represented only 0.1% of the total enzyme activity.


Figure 3. Kinetics of fed-batch production of truncated human Fuc-TIII enzyme by a methanol-induced Pichia pastoris GS115 strain. The secretion of enzyme by P.pastoris was followed by measuring Fuc-TIII activity (c.p.m./h·l) in the medium (solid circles) and in cells (open circles). One unit of biomass (A600) corresponded to 5·107 cells/ml (+).


SDS-PAGE of supernatant proteins, revealed a major band at 43 kDa representing about 10% of the whole. This protein was identified as the truncated Fuc-TIII by immunoblotting analysis using an anti-Fuc-TIII antibody (Figure 4, lanes 1 and 2).


Figure 4. Electrophoretic mobility of truncated Fuc-TIII enzyme. Lanes 1 and 2 correspond to proteins present in the growth medium; lanes 3 and 4 to the enzyme purified by affinity chromatography (AC) on GDP-Fractogel. Supernatant culture (20 µl) or AC effluent (15 µl) was loaded on a 12.5% SDS-polyacrylamide gel. Lanes 1 and 3 correspond to silver stained gel; Western blots of gels stained with an anti-Fuc-TIII antibody are presented in lanes 2 and 4. Ovalbumin (43 kDa), carbonic anhydrase (29 kDa), and [beta]-lactoglobulin (18 kDa) were used as molecular mass standards.

Since the total supernatant proteins obtained in a 1 l fed-batch process was approximately 300 mg, the amount of recombinant enzyme was close to 30 mg. To purify the Fuc-TIII enzyme (inhibited at about 70% by antifoam added into the fermentor), we performed an affinity chromatography of supernatant proteins on GDP-Fractogel as described in Materials and methods. Based on this experiment, we determined that the overall enzyme concentration was 11.3 U per liter with an approximate specific activity of 400 mU/mg protein. The purified protein was clearly detected by silver staining and Western blotting as a 43 kDa band (Figure 4, lanes 3 and 4).

Substrate specificity of soluble enzyme and cell-enclosed enzyme as reusable catalyst

In order to assess in vitro substrate acceptor pattern of the truncated enzyme, activity was determined with various type 1, type 2, Lea, and Lex acceptors, and compared to that of full length enzyme produced in COS7 cells transfected with the human FUT3 gene (Table III). The analysis demonstrated that the truncated enzyme synthesized very efficiently Leb and at lower rate Lea, Gal[alpha]1,3-Lea, and sLea. Similar results were obtained for the Fuc-TIII enzyme produced in COS7 cells. Under our conditions, type 2 acceptors were very poor substrates for Fuc-TIII enzyme. No transfer activity was detected with three of the four type 2 acceptors tested; H-type 2 accounted for 3-4% of the activity measured with type 1 acceptor (Table III). However, it has been shown (Lubineau et al., 1998) that fucose transfer on type 2 acceptors occurs at higher acceptor concentrations (5, 10, 20 mM). On the other hand, a very low [alpha](1,2) fucose transfer activity (3 or 4%) was measured with Lea as a substrate acceptor, whatever the recombinant Fuc-TIII enzyme used (data not shown).

Table III. Relative substrate acceptor specificities of human Fuc-TIII recombinant enzyme produced in P.pastoris and COS 7 cells
Acceptor oligosaccharides Truncated
enzyme (1)
Full-length
enzyme (2)
Type 1
Gal[beta]1-3GlcNAc-R(3) 100 100
Fuc[alpha]1-2Gal[beta]1-3GlcNAc-R(5) 270 230
Gal[alpha]1-3Gal[beta]1-3GlcNAc-R(3) 135 ND
NeuAc[alpha]2-3Gal[beta]1-3GlcNAc-R(5) 90 60
Type 2
Gal[beta]1-4GlcNAc-R(4) 0 0
Fuc[alpha]1-2Gal[beta]1-4GlcNAc-R(5) 3 4
Gal[alpha]1-3Gal[beta]1-4GlcNAc-R(4) 0 ND
NeuAc[alpha]2-3Gal[beta]1-4GlcNAc-R(5) 0 0
The reference value (100) corresponded to 11,050 c.p.m. and 9207 c.p.m. for Pichia pastoris and COS7 cells respectively, according to assay conditions described in Materials and methods. (1) Produced in Pichia pastoris; (2) produced in COS7 cells; (3) R: -(CH2)7CH3; (4) -(CH2)8COOCH3; (5) R: -O-sp-biotin. ND, Not determined.

By analyzing the rate of formation of fucosylated products at various concentrations of the type 1 acceptors, the Km and Vmax values were determined (Table IV). The affinity of the truncated Fuc-TIII enzyme for type 1precursor was 4-, 2.5-, and 2-fold lower than for H-type 1, Gal[alpha]1-3-type 1, and sialyl-type 1, respectively. The Vmax for the former substrate was 21 times and 15 times lower than with H-type 1 and Gal[alpha]1-3-type 1, respectively, and of the same magnitude for the sialyl-type 1.

To test the ability of cell-enclosed Fuc-TIII enzyme to stand up to successive assay and storage periods, repeated freezing and thawing cycles were carried out using 2·108 and 5·107 cells, respectively (Figure 5). A steady decrease (about 5%) of Fuc-TIII activity occurred when assays were performed on 5·107 cells during 4 h with the type 1 substrate as an acceptor. Using 2·108 cells and an incubation time of 1 h, enzyme activity remained stable over 5 cycles with a marked activity increase during the first two cycles (35 and 20%, respectively).


Figure 5. Cell-enclosed Fuc-TIII enzyme as reusable catalyst. Recombinant Pichia cells (2·108 or 5·107) were subjected to successive phases of thawing, enzymatic assay, and freezing. One cycle (48 h of length), corresponded to the successive phases. Upon incubation with type 1 substrate for 1 h (solid circles) or 4 h (open circles) (see Materials and methods), cells were harvested by centrifugation, frozen at -20°C for 48 h, then thawed to initiate a new cycle.

Discussion

The construction of a truncated form of human [alpha](1,3/4) fucosyltransferase was undertaken with the aim to produce a soluble form of enzyme. This was made by deleting the first 134 nucleotides of the FUT3 coding sequence. This results in a soluble protein deleted of its first 44 amino acids and presenting four N-ter additional amino acids (Tyr-Val-Glu-Phe). Surprisingly, no Fuc-TIII activity is detected in the culture broth before 30 h of induction. Such a phenomenon, already described by Tschopp et al. (1987) for invertase production with reference to pulse-chase experiments, has been attributed to a slow secretion rate by Pichia cells. To substantiate this observation, we show here that the enzyme (85.5% of activity) accumulates in exocytosis vesicles and in the periplasmic space before its release in culture broth (Table II, Figure 3). We also show that the cell-enclosed enzyme was firmly trapped inside the cell wall, although substrates and products could be freely exchanged (Figure 5). Furthermore, there is an unexpected increase of enzyme activity during the first two cycles of freezing and thawing suggesting a release of exocytosis vesicle-enclosed enzyme, which compensates for the loss of activity due to the physical treatment and even gives an apparent increase of the enzyme activity (Figure 5).

Table IV. Km and Vmax values of truncated human Fuc-TIII recombinant enzyme
Acceptor substrate Km (mM) Vmax (nmol/min·mg) Relative efficiency (Vmax/Km)
Gal[beta]1-3GlcNAc-R(1) 0.4 0.6 1.5
Fuc[alpha]1-2Gal[beta]1-3GlcNAc-R(2) 0.1 12.8 128
Gal[alpha]1-3Gal[beta]1-3GlcNAc-R(1) 0.16 8.9 55.8
NeuAc[alpha]2-3Gal[beta]1-3GlcNAc-R(2) 0.2 0.4 2
Assay conditions are described in Materials and methods. The apparent kinetic parameters were determined from Michaelis-Menten curve fit to the experimental data using the least squares method. (1) R: -(CH2)7CH3; (2) R: -O-sp-biotin.

The soluble form of fucosyltransferase accounted for 10% of the whole supernatant proteins so that its purification could be achieved by a single chromatography step using GDP-Fractogel (Figure 4). From the difference observed (5 kDa) between the apparent molecular mass of the purified protein (43 kDa) and the unglycosylated polypeptide (38 kDa), it was suggested that the well known two putative glycosylation sites are occupied by oligomannosidic glycans, accounting for about 20 mannose residues.

Just like the enzyme produced by COS7 cells, the truncated enzyme secreted by Pichia cells, showed virtually no or very low activities with type 2 acceptors. Using differently truncated Fuc-TIII enzymes, De Vries et al. (1995) and Costa et al. (1997) obtained similar results, whereas Costache et al. (1997) found 1% and Johnson et al. (1993) 10% of enzyme activity as compared to the type 1 acceptor substrate. This difference might be due to the truncated form of the enzyme secreted by P.pastoris, or the peculiar in vitro assay conditions applied. It should be emphasized that solubilization of membrane-bound glycosyltransferases, after disruption of COS7 cells in the presence of detergents, frequently results in a mixture of proteolytically cleaved and intact forms, which makes difficult the in vitro assessment of the substrate specificity with the native Golgi enzymes. However, when coexpressing the human erythropoietin and Fuc-TIII in BHK cells, Costa et al. (1997) did not detect peripheral fucosylation of the secreted erythropoietin, a result that supports the view that the enzyme acts in vivo as a [alpha](1,4) fucosyltransferase only. Since Colo 205 [alpha](1,3/4) fucosyltransferase can synthesize a Leb motif from a Lea acceptor substrate (Chandrasekaran et al., 1995), the [alpha](1,2) fucosyltransferase activity of truncated Fuc-TIII enzyme was assayed with Lea and Lex acceptor substrates. Both truncated and full length recombinant enzymes catalyzed, at a very low level, the [alpha](1,2) fucosylation of terminal galactose with Lea as an acceptor. This is not surprising since similar small amounts of A and B oligosaccharide products were found to be made by the opposite B and A enzymes, respectively (reviewed in Watkins et al., 1988), suggesting that a weak cross-enzyme activity might be a more common than expected feature of glycosyltransferases.

Finally, the heterologous expression of an engineered truncated form of human fucosyltransferase III has been successfully performed (about 30 mg/l culture broth) for the first time by the methylotrophic yeast Pichia pastoris. It presents the same catalytic properties as its full length form. Considering the medical and pharmacological importance of fucosyltransferases, this new heterologous expression system could be useful to provide the amount of protein required for structural studies and chemo-enzymatic synthesis. Moreover these recombinant Pichia pastoris cells have been already used for the fucosylation of a sulfated tetrasaccharide of Lewis x type (Lubineau et al., 1998).

Materials and methods

Materials

Plasmid pPIC9 and P. pastoris strain GS115 (his4) were obtained from InVitrogen (San Diego, CA). Type 1 and Gal[alpha]1-3-type 1-O-octyl were synthesized according to Augé et al. (1976) and to Lubineau et al., (1996), respectively. Dr. M. Palcic (Alberta Research Council, Edmonton, Canada) kindly provided the 8-methoxycarbonyloctyl type 2. H-Type 1-sp-biotin, H-type 2-sp-biotin, Lea-sp-biotin, Lex-sp-biotin, sialyl-type 1-O-sp-biotin, and sialyl-type 2-O-sp-biotin were purchased from Synthesome (Russia). GDP-Fractogel was a generous gift of Dr. H. Conradt (Protein Glycosylation, Braunschweig, Germany). Enzymes for DNA manipulations were obtained from Boehringer Mannheim Biochemicals (Mannheim, Germany) or New England Biolabs (Beverly, MA). Yeast extract, bactopeptone, and yeast nitrogen base were from Difco Laboratories (Detroit, MI). All other reagents were of molecular biology grade.

Transfection and expression of the FUT3 gene in COS7 cells

DNA sequence corresponding to the FUT3 gene (1125 bp) was obtained by amplification of the FUT3 cDNA (Mollicone et al., 1994). The amplified fragment containing the two engineered sites EcoRI/XbaI was digested with the respective enzymes and cloned between the EcoRI/XbaI restriction sites of the mammalian expression vector pcDNAI (Invitrogen) to give the pFUT3 vector. COS7 cells were transfected with DEAE-dextran (Davis et al., 1986) and harvested after a 48 h expression period (Weston et al., 1992).

Cloning of the truncated FUT3 gene into the pPIC9 expression vector

Routine cloning experiments were performed as described previously (Ausubel et al.,1989; Sambrook et al., 1989).

The pPIC9[FUT3] vector corresponded to the EcoRI/XbaI FUT3 fragment (1125 bp) excised from the pFUT3 vector and cloned into pPIC9. The pPIC9[FUT3t] vector resulted from cloning of the truncated FUT3 gene (AvrII/NotI digestion of pPIC9[FUT3]) in a pPIC9 plasmid (Figure 1).

The Pichia strain GS115 (his4) was transformed by electroporation (1500 V, 25 µF and 200½, Bio-Rad Gene Pulser) with 10 µg of SalI linearized pPIC9[FUT3t] vector and plated onto a histidine devoid RDB medium (1 M sorbitol, 1% (w/v) dextrose, 1.34% (w/v) YNB, 4·10-5 % (w/v) biotin, 5·10-3% (w/v) of each l-glutamic acid, l-methionine, l-lysine, l-leucine, and l-isoleucine). The integration at the expected locus was checked by replica plating on MM and MD agar (1.34% (w/v) YNB, 4·10-5% (w/v) biotin and 0.5% (v/v) methanol or 1% (w/v) dextrose). Colonies were allowed to grow for 2 days at 30°C. Clones that grew rapidly on MM medium were picked for further investigation.

PCR analysis of Pichia integrants

Yeast genomic DNAwas extracted according to Ausubel et al. (1989), from selected clones grown overnight in 5 ml YPD medium (1% (w/v) yeast extract, 2% (w/v) bactopeptone, and 2% (w/v) dextrose) at 30°C.

PCR was performed in a mixture containing 50 mM KCl, 10 mM Tris-HCl (pH 9), 1 mM MgCl2, 100 µM of each dNTP, 1 µl of genomic DNA (about 100 ng), 10 pmol of PCR primers (5[prime]AOX1 : 5[prime]-GACTGGTTCCAATTGACAAGC-3[prime]; 3[prime]AOX1 : 5[prime]-GCAAATGGCATTCTGACATCC-3[prime]) and 1.25 U of Taq DNA polymerase (Promega) in a total volume of 25 µl. After heating at 94°C for 3 min, 25 cycles were performed (denaturation at 94°C for 1 min, annealing at 55°C for 1 min, and extension at 72°C for 1 min). PCR products were analyzed on 1% (w/v) agarose gel electrophoresis.

Subcellular localization of Fuc-TIII activity

Subcellular fractionation of yeast cells was made as described by Gallet et al. (1995). Cells (48 h) were harvested by centrifugation (3000 × g for 5 min and 4°C) and washed in cold distilled water and then by mannitol/Tris buffer (0.6 M mannitol, 10 mM Tris-HCl pH 7.4). Cells were suspended in the same buffer and broken with acid-washed glass beads (6 × 30 s at 4°C). The homogenate was centrifuged at 1000 × g for 5 min and 4°C to pellet glass beads and unbroken cells. The resulting supernatant was centrifuged at 3600 × g for 5 min and 4°C to pellet cell walls. The nuclear fraction was obtained by centrifugation at 5000 × g for 5 min at 4°C while mitochondria were pelleted at 25,000 × g for 10 min and 4°C. The microsomal fraction was then sedimented at 120,000 × g for 1 h and 4°C. The resulting supernatant represented the cytosolic and periplasmic space fractions.

Pichia expression studies

Yeast preculture was made in 10 ml of MG medium (1.34% (w/v) yeast nitrogen base, 4·10-5% (w/v) biotin, 1% (v/v) glycerol) for 12 h at 30°C to A60 0 = 4. Cells harvested by centrifugation (3000 × g for 5 min and 20°C) and washed with 10 ml of 1.34% (w/v) YNB, were then mixed to 10 ml of MM medium (A600 = 1). Induction was carried out for 48 h with 1% (v/v) methanol under vigorous shaking at 30°C. Cells were harvested by centrifugation (3000 × g for 5 min and 4°C), washed with cold water, and suspended in 2.5 mM sodium cacodylate, pH 6.5. Cell breakage was made as described above. The protein content was determined by the Bradford assay (Bio-Rad) using bovine serum albumin as a standard (Bradford, 1976).

Fermentation

The inoculum for enzyme production, was obtained from 200 ml of overnight MG medium culture (A600 = 10). Cells were harvested by centrifugation 3000 × g for 10 min and 20°C, washed by 50 ml of 0.67% (w/v) YNB and diluted to A600 = 0.86 in the growth medium composed of 0.67% (w/v) YNB and 4·10-5 % (w/v) biotin. During the 169 h induction, pH was maintained at 6.0 with 28% (v/v) ammonium hydroxide and temperature to 30°C. Methanol was continually added at a flow of 5 g/l·h. Agitation speed was 600 r.p.m., and air flow was 2.5 l per min. A supplement of YNB/biotine 5× was added to account for water evaporation. To prevent extensive foam formation, antifoam A (Sigma) was added. At the end (169 h), the culture was harvested by centrifugation 3000 × g for 10 min and 4°C. Supernatant and cells were recovered and stored at -20°C.

SDS-PAGE and Western blot analysis

Culture supernatant (20 µl) was analyzed by SDS-PAGE using a 12.5% acrylamide Tris-Tricine gel (SchSgger and Von Jagow, 1987). Proteins were visualized by silver staining (Blum et al., 1987). The amount of Fuc-TIII enzyme was determined by densitometry analysis (Vilbert-Lourmat, BioProfil software). Proteins were transferred onto nitrocellulose membrane (Schleicher & Schuell, Germany) which was blocked overnight at 4°C by phosphate-buffered saline containing 1% (v/v) Tween 20 and 5% (w/v) bovine serum albumin (PBS-T-BSA). After three washings in PBS-T, the membrane was incubated for 1 h at 20°C with a rabbit anti-Fuc-TIII antibody in PBS-T-BSA buffer at 1:500 dilution. Donkey anti-rabbit immunoglobulin coupled to horseradish peroxidase (Amersham, England), was used at 1:1000 dilution. The blots were developed according to the ECL detection Kit (Amersham, England).

Protein purification

Fifty milliliters of the culture broth were centrifuged for 20 min at 18,000 × g and 4°C and applied onto a 2 ml GDP-Fractogel column equilibrated with 20 mM Mes-KOH, pH 6.8, containing 0.02% (w/v) NaN3 and 1 mM dithiothreitol at a flow rate of 0.8 ml·min-1 at room temperature. The column was washed by 20 mM Mes-KOH buffer, pH 6.8 (19 ml), containing 50 mM NaCl, 0.02% (w/v) NaN3, and 30% (v/v) glycerol at a flow rate of 0.8 ml·min-1 and the same buffer (19 ml) containing 500 mM NaCl at the same flow rate. The enzyme was eluted from the column by the same buffer (14 ml) containing 1.5 M NaCl at a flow rate of 0.4 ml·min-1. The eluted fraction was stored at -20°C or precipitated by 1 volume of acetone/[beta]-mercaptoethanol 0.7% (v/v) at -20°C for 24 h. After centrifugation for 1 h at 100,000 × g and 4°C, the protein pellet was suspended in 30 µl of elution buffer and analyzed by SDS-PAGE and immunoblotting.

Fucosyltransferase assay

Fucosyltransferase assays were performed according to Oulmouden et al. (1997). The enzyme activity with type 1, type 2, Lea, or Lex glycoside acceptors was tested at 37°C in 60 µl of the following reaction mixture: 25 mM sodium cacodylate, pH 6.5, 5 mM ATP, 20 mM MnCl2, 10 mM [alpha]-l-fucose, 2.8 µM GDP-[14C]fucose (168 pmol/100,000 c.p.m.). Acceptors were used at 0.1 mM. The reaction was initiated by addition of 34 µl of culture broth or 108 whole yeast cells or 50 µg of COS7 cell proteins. After 1 h of incubation, the reaction was stopped by addition of 3 ml of cold water, then centrifuged at 3000 x g for 5 min and 20°C. The supernatant was applied onto Sep-Pak C18 cartridges, which were washed with 10 ml of water. The products were eluted with 10 ml methanol. The incorporation of [14C]fucose was determined by liquid scintillation counting.

Enzyme kinetics was performed in reaction mixtures as described above except that the concentrations of the type 1, H-type 1, Gal[alpha]1-3-type 1, and sialyl-type 1 acceptors varied from 0 to 0.1 mM and GDP-[14C]fucose was 7 µM. The apparent kinetic parameters were determined from Michaelis-Menten curves fit to the experimental data using the least square method.

After GDP-Fractogel purification, the enzyme activity was measured in the presence of type 1 acceptor as described above, except that 0.2 mM (12.12 nmol/100,000 c.p.m.) GDP-Fucose was used. One unit of enzyme activity was defined as the amount of enzyme catalyzing the transfer of 1 µmol of fucose/min to the octyl-glycoside type 1 substrate.

To determine enzyme stability, 48 h methanol-induced Pichia cells (1 ml) were pelleted by centrifugation at 3000 × g for 5 min and 4°C, washed with cold distilled water, and suspended into 1 ml of 25 mM sodium cacodylate, pH 6.5. Aliquots of 2·108 and 5·107 cells were used to determine the Fuc-TIII activity. The reaction mixture was as described above, with 0.1 mM type 1 acceptor and 2.8 µM GDP-[14C]fucose. The incubation times were 1 and 4 h for 2·108 and 5·107 cells, respectively. The reaction was stopped with 3 ml of cold distilled water. The suspension was centrifuged at 3000 × g for 5 min and 4°C to pellet cells which were immediately stored at -20°C.

Acknowledgments

We thank Dr. M. Palcic for supplying the 8-methoxycarbonyloctyl type 2 acceptor substrate. The gift of anti-Fuc-TIII antibody by Dr. J. Lowe is gratefully acknowledged. We thank Dr. H. Conradt for providing the GDP-Fractogel. This work was supported by the MENRT: ACCSV14 N°9514111 Réseau GTRec and the Biotech immunology program, DGXII, from the European Union.

Abbreviations

Fuc-TIII, GDP-l-fucose:[beta]-d-N-acetyl-glucosaminide 4-[alpha]-l-fucosyltransferase; Lea, Lewis a; Lex, Lewis x; Leb, Lewis b; sLea, sialyl-Lewis a; sLex, sialyl-Lewis x; YNB, yeast nitrogen base.

References

Augé ,C. and Veyrières,A. (1976) Synthesis of a disaccharide oxazoline: 2-methyl-[4,6-di-O-acetyl-1,2-dideoxy-3-O-(2,3,4,6-tetra-O-acetyl-[beta]-d-galactopyranosyl)-[alpha]-d-glucopyranol] [2[prime],1[prime] : 4,5]-2-oxazoline. Carbohydr. Res.,46, 293-298.

Ausubel ,F.M., Brent,R., Kingston,R.E., Moore,D.D., Smith,J.A., Seidman,J.G. and Struhl,K. (1989) Current Protocols in Molecular Biology. Wiley, New York.

Berg ,E.L., Magnani,J., Warnock,R.A., Robinson,M.K. and Butcher,E.C. (1992) Comparison of L-selectin and E-selectin ligand specificities: the L-selectin can bind the E-selectin ligands sialyl Le(x) and sialyl Le(a). Biochem. Biophys. Res. Commun., 184, 1048-1055. MEDLINE Abstract

Blum ,H., Beier,H. and Gross,H.J. (1987) Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis, 8, 93-99.

Bradford ,M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254. MEDLINE Abstract

Chandrasekaran ,E.V., Jain,R.K., Rhodes,J.M., Srnka,C.A., Larsen,R.D. and Matta,K.L. (1995) Expression of blood group Lewis b determinant from Lewis a: association of this novel [alpha](1,2)-l-fucosylating activity with the Lewis type [alpha](1,3/4)-l-fucosyltransferase. Biochemistry, 34, 4748-4756. MEDLINE Abstract

Costa.J. , Grabenhorst,E., Nimtz,M. and Conradt,H.S. (1997) Stable expression of the Golgi form and secretory variants of human fucosyltransferase III from BHK-21 cells. Purification and characterization of an engineered truncated form from the culture medium. J. Biol. Chem., 272, 11613-11621. MEDLINE Abstract

Costache ,M., Apoil,P.A., Cailleau,A., Elmgren,A., Larson,G., Henry,S., Blancher,A., Iordachescu,D., Oriol,R. and Mollicone,R. (1997) Evolution of fucosyltransferase genes in vertebrates. J. Biol. Chem., 272, 29721-29728. MEDLINE Abstract

Cregg ,J.M., Vedvick,T.S. and Raschke,W.C. (1993) Recent advances in the expression of foreign genes in Pichia pastoris. Bio/Technology, 11, 905-910. MEDLINE Abstract

Davis ,L.G., Dibner,M.D. and Battey,J.F. (1986) Basic Methods in Molecular Biology. Elsevier Science Publishing, New York, pp. 290-292.

De Vries ,T., Srnka,C.A., Palcic,M.M., Swiedler,S.J., van den Eijnden,D.H. and Macher,B.A. (1995) Acceptor specificity of different length constructs of human recombinant [alpha](1,3/4)-fucosyltransferases. Replacement of the stem region and the transmembrane domain of fucosyltransferase V by protein A results in an enzyme with GDP-fucose hydrolyzing activity. J. Biol. Chem., 270, 8712-8722. MEDLINE Abstract

Ellis ,S.B., Brust,P.F., Koutz,P.J., Waters,A.F., Harpold,M.M. and Gingeras,T.R., (1985) Isolation of alcohol oxidase and two other methanol regulatable genes from the yeast Pichia pastoris. Mol. Cell. Biol., 5, 1111-1121. MEDLINE Abstract

Foxall ,C., Watson,S.R., Dowbenko,D., Fennie,C., Lasky,L.A., Kiso,M., Hasegawa,A., Asa,D. and Brandley,B.K. (1992) The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide. J. Cell Biol., 117, 895-902. MEDLINE Abstract

Gallet ,P.F., Maftah,A., Petit,J.M., Denis-Gay,M. and Julien,R. (1995) Direct cardiolipin assay in yeast using the red fluorescence emission of 10-N-nonyl acridine orange. Eur. J. Biochem., 228, 113-119. MEDLINE Abstract

Johnson ,P.H., Donald,A.S. and Watkins,W.M. (1993) Purification and properties of the [alpha](3/4)-l-fucosyltransferase released into the culture medium during the growth of the human A431 epidermoid carcinoma cell line. Glycoconj. J., 10, 152-164. MEDLINE Abstract

Kukowska-Latallo ,J.F., Larsen,R.D., Nair,R.P. and Lowe,J.B. (1990) A cloned human cDNA determines expression of mouse stage-specific embryonic antigen and the Lewis blood group [alpha](1,3/1,4)fucosyltransferase. Genes Dev., 4, 1288-1303. MEDLINE Abstract

Lowe ,J.B., Stoolman,L.M., Nair,R.P., Larsen,R.D., Berhend,T.L. and Marks,R.M. (1990) ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA. Cell, 63, 475-484. MEDLINE Abstract

Lubineau ,A., Le Narvor,C., Augé,C., Gallet,P.F., Petit,J.M. and Julien,R. (1998) Chemo-enzymatic synthesis of a selectin ligand using recombinant yeast cells. J. Mol. Catal. B: Enzymic, in press.

Marcus ,D.M. and Cass,L.E. (1969) Glycosphingolipids with Lewis blood group activity: uptake by human erythrocytes. Science, 164, 553-555. MEDLINE Abstract

Mollicone ,R., Reguigne,I., Kelly,R.J., Fletcher,A., Watt,J., Chatfield,S., Aziz,A., Cameron,H.S., Weston,B.W., Lowe,J.B. and Oriol,R. (1994) Molecular basis for Lewis [alpha](1,3/1,4)-fucosyltransferase gene deficiency (FUT3) in Lewis-negative Indonesian pedigrees. J. Biol. Chem., 269, 20987-20994. MEDLINE Abstract

Oriol ,R., Le Pendu,J. and Mollicone,R. (1986) Genetics of ABO, H, Lewis, X and related antigens. Vox Sang., 51, 161-171. MEDLINE Abstract

Oulmouden ,A., Wierinckx,A., Petit,J.M., Costache,M., Palcic,M.M., Mollicone,R., Oriol,R. and Julien,R. (1997) Molecular cloning and expression of a bovine [alpha](1,3)-fucosyltransferase gene homologous to a putative ancestor gene of the human FUT3-FUT5-FUT6 cluster. J. Biol. Chem., 272, 8764-8773. MEDLINE Abstract

Sambrook ,J., Fritsch,E.F. and Maniatis,T.L. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

Schägger ,H. and VonJagow,G. (1987) Tricine-sodium dodecyl sulfate polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem., 166, 368-379.

Takada ,A., Ohmori,K., Takahashi,N., Tsuyuoka,K., Yago,A., Zenita,K., Hasegawa,A. and Kannagi,R. (1991) Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis a. Biochem. Biophys. Res. Commun., 179, 713-719. MEDLINE Abstract

Tschopp ,J.F., Sverlow,G., Kosson,R., Craig,W. and Grinna,L. (1987) High-level secretion of glycosylated invertase in the methylotrophic yeast, Pichia pastoris. Bio/Technology, 5, 1305-1308.

Walz ,G., Aruffo,A., Kolanus,W., Bevilacqua,M. and Seed,B. (1990) Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science, 250, 1132-1135. MEDLINE Abstract

Watkins ,W.M., Greenwell,P., Yates,A.D. and Johnson,P.H. (1988) Regulation of expression of carbohydrate blood group antigens. Biochimie, 70, 1597-1611. MEDLINE Abstract

Weston ,B.W., Smith,P.L., Kelly,R.J. and Lowe,J.B. (1992) Molecular cloning of a fourth member of a human [alpha](1,3)fucosyltransferase gene family. Multiple homologous sequences that determine expression of the Lewis x, sialyl-Lewis x, and difucosyl sialyl-Lewis x epitopes. J. Biol. Chem., 267, 24575-24584. MEDLINE Abstract


3To whom correspondence should be addressed at: Institut de Biotechnologie, 123 Avenue Albert Thomas, F-87060 Limoges Cedex, France


This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: www-admin{at}oup.co.uk
Last modification: 22 Jul 1998
Copyright©Oxford University Press, 1998.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
H. Abe, Y.-i. Shimma, and Y. Jigami
In vitro oligosaccharide synthesis using intact yeast cells that display glycosyltransferases at the cell surface through cell wall-anchored protein Pir
Glycobiology, February 1, 2003; 13(2): 87 - 95.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
Z. C. Chen, M. Tanemura, and U. Galili
Synthesis of {{alpha}}-gal epitopes (Gal{{alpha}}1-3Gal{beta}1-4GlcNAc-R) on human tumor cells by recombinant {{alpha}}1,3galactosyltransferase produced in Pichia pastoris
Glycobiology, July 1, 2001; 11(7): 577 - 586.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Rasko, G. Wang, M. M. Palcic, and D. E. Taylor
Cloning and Characterization of the alpha (1,3/4) Fucosyltransferase of Helicobacter pylori
J. Biol. Chem., February 18, 2000; 275(7): 4988 - 4994.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Dupuy, J.-M. Petit, R. Mollicone, R. Oriol, R. Julien, and A. Maftah
A Single Amino Acid in the Hypervariable Stem Domain of Vertebrate alpha 1,3/1,4-Fucosyltransferases Determines the Type 1/Type 2 Transfer. CHARACTERIZATION OF ACCEPTOR SUBSTRATE SPECIFICITY OF THE LEWIS ENZYME BY SITE-DIRECTED MUTAGENESIS
J. Biol. Chem., April 30, 1999; 274(18): 12257 - 12262.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. H. Holmes, T.-Y. Yen, S. Thomas, R. Joshi, A. Nguyen, T. Long, F. Gallet, A. Maftah, R. Julien, and B. A. Macher
Human alpha 1,3/4 Fucosyltransferases. CHARACTERIZATION OF HIGHLY CONSERVED CYSTEINE RESIDUES AND N-LINKED GLYCOSYLATION SITES
J. Biol. Chem., August 4, 2000; 275(32): 24237 - 24245.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gallet, P. F.
Right arrow Articles by Julien, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gallet, P. F.
Right arrow Articles by Julien, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?